Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-03

Clinical Trial Update: Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry Eye [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Vizol S DIGI EYE for Dry Eye Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vizol S DIGI EYE

Snippet

Sponsor: Jadran Galenski laboratorij d.d. | Conditions: Dry Eye Disease (DED) | Phase 3 | Status: COMPLETED